NGeneBio

Business Services · South Korea · 51-200 Employees

View Company Info for Free

Overview

Headquarters

#303-307 904ho 288, Guro-gu, Seoul, Sout...

Phone Number

+82 28679798

Revenue

$5.4 Million

Industry

Business Services Software Manufacturing Healthcare Software Healthcare Services Research & Development Medical Devices & Equipment Medical Laboratories & Imaging Centers
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About NGeneBio

NGeneBio Co., Ltd. is a leading company in molecular diagnostics (MDx) and companion diagnostics (CDx), which develops and provides next generation sequencing (NGS)-based in vitro diagnostics (IVD) panel and clinical analysis software (SW). NGeneBio was founded in October 2015, headquartered in Seoul, South Korea as a joint venture between Genecurix and Korea Telecom. The company launched NGS-based hereditary breast/ovarian cancer panel (BRCAaccuTestTM) with clinical analysis SW (NGeneAnalysisTM) in 2016. BRCA NGS panel for PARP inhibitor CDx test and solid tumor/hematologic cancer NGS panels will be launched, inclusive of clinical data analysis SW platform. The mission of the company is to provide clinically validated NGS based IVD/CDx products/services with convergence of innovative bioinformatics and SW development capacity for global market.Explore more
NGeneBio's Social MediaPopular SearchesNGeneBio Co LtdNGeneBioNGeneBio Co. LtdSIC Code 87,873NAICS Code 54,541Show more

NGeneBio Org Chart

Daech Choi, Chief Executive Officer at NGeneBio
South Korea flag for contact location.

Chief Executive Officer

PhoneEmail
KK
South Korea flag for contact location.

Chief Technology Officer

PhoneEmail
SY
South Korea flag for contact location.

Chief Financial Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
KL
South Korea flag for contact location.

Centre Director, Research & Development

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is NGeneBio your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

NGeneBio is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

NGeneBio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about NGeneBio.

NGeneBio financials insights

Gather financial insights about NGeneBio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2021

Stock Offering

$32M

See All NGeneBio's Financials Insights

NGeneBio Tech Stack

A closer look at the technologies used by NGeneBio

Top Business Services Companies

Frequently Asked Questions Regarding NGeneBio

What is NGeneBio's official website?
NGeneBio's official website is www.ngenebio.com
What is NGeneBio's Revenue?
NGeneBio's revenue is $5.4 Million
What is NGeneBio's SIC code?
NGeneBio's SIC: 87,873
What is NGeneBio's NAICS code?
NGeneBio's NAICS: 54,541
How many employees does NGeneBio have?
NGeneBio has 51-200 employees
What industry does NGeneBio belong to?
NGeneBio is in the industry of: Business Services, Software, Manufacturing
What companies has NGeneBio acquired?
NGeneBio has acquired the companies: Toplab
What technology does NGeneBio use?
Some of the popular technologies that NGeneBio uses are: WordPress.org, PHP, Google Universal Analytics, Cloudflare CDN
Who is the CFO of NGeneBio?
NGeneBio's CFO is Sehyuk Yoon
Who is the CTO of NGeneBio?
NGeneBio's CTO is Kwang Kim
How do I contact NGeneBio?
NGeneBio contact info: Phone number: +82 28679798 Website: www.ngenebio.com
What does NGeneBio do?

NGeneBio Co., Ltd. is a leading company in molecular diagnostics (MDx) and companion diagnostics (CDx), which develops and provides next generation sequencing (NGS)-based in vitro diagnostics (IVD) panel and clinical analysis software (SW). NGeneBio was founded in October 2015, headquartered in Seoul, South Korea as a joint venture between Genecuri... x and Korea Telecom. The company launched NGS-based hereditary breast/ovarian cancer panel (BRCAaccuTestTM) with clinical analysis SW (NGeneAnalysisTM) in 2016. BRCA NGS panel for PARP inhibitor CDx test and solid tumor/hematologic cancer NGS panels will be launched, inclusive of clinical data analysis SW platform. The mission of the company is to provide clinically validated NGS based IVD/CDx products/services with convergence of innovative bioinformatics and SW development capacity for global market.Read More

What are NGeneBio social media links?
NGeneBio Linkedin page NGeneBio Twitter page NGeneBio Facebook page
Is NGeneBio a public company?
NGeneBio is private company therefore does not currently have an official ticker symbol
See more information about NGeneBio

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.